People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Advanced Molecular Imaging, LLC | — | Other Health Care | Series A | $17.9M | $71.6M | 2009 |
| TheraCell, Inc. | — | Biotechnology | Seed | $1.3M | $59.7M | 2009 |
Jan S. Iwanczyk at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jan S. Iwanczyk on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bradley E. Patt | 2 | 3 |
| Joseph M. Miller | 2 | 2 |
| Albert S. Waxman | 1 | 3 |
| Danny M. Gazit | 1 | 1 |
| Nicolas J. Scola | 1 | 1 |
| Svein S. Jacobsen | 1 | 1 |
| David S. Eichler | 1 | 1 |
| Frank M. Phillips | 1 | 1 |
| Richard K. Grant | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.